Baxter Biopharma Solutions Articles
World's first long-lasting hemophilia therapies will see Biogen move ahead of Pfizer and Baxter
23 April 2013
Five new drugs for myelodysplastic syndromes set to launch by 2018
10 February 2013
Ipsen and Inspiration Biopharma in deal with Baxter for OBI-1
24 January 2013
Study attacks Pharma business practices in Brazil
11 December 2012
News briefs: Rituximab biosimilar; Watson to change name; Baxter Brazil plans; India revokes Pegasys patent
5 November 2012
Baxter in up to $565 million deal with Onconova for rigosertib
20 September 2012
News briefs: setbacks for B-MS hep C drug; Baxter's HyQ
2 August 2012
Halozyme plunges as FDA call for more data on HyQ BLA
17 April 2012
Baxter taps Momenta expertise on biosimilars
28 December 2011
Baxter to acquire Synovis
14 December 2011
Baxter pays $380 million to acquire drug delivery firm Baxa
27 August 2011
US FDA approves KV Thera/Ther-Rx’ Makena, first drug to reduce risk of preterm birth in at-risk pregnant women
7 February 2011
Baxter buys all hemophilia-related assets of Archemix for $30 million and $285 million in potential milestones
22 November 2010
US FDA briefs: fast-track for Zeltia’s Zentylor; OK for Baxter’s Protopam; warning on gadolinium-based contrast agents
13 September 2010
Israel’s Kamada to get $45 million from distribution deal with Baxter for Glassia in North America and Australia/NZ
26 August 2010
Europe’s CHMP updates on pandemic vaccines, backs use extensions for Reyataz and RoActemra, concludes Seroquel XR arbitration
26 April 2010
WHO’s pandemic advisor strongly denies industry influence in “false flu pandemic fiasco;” GSK says same
18 January 2010
UK govt in talks with GlaxoSmithKline to offload swine flu vaccine stocks as pandemic fails to materialize
11 January 2010
Class action against Australia’s CSL widens with US university claimant; Medicines Australia appoints permanent CEO
11 January 2010
Drug evaluation in the UK: have we got it right? asks the NICE
7 December 2009
European Commission tops a billion euros invested in the fight against the global AIDS epidemic; clears new pandemic flu vaccine use
1 December 2009
Meeting highlights from Europe’s CHMP November 16-19, 2009
23 November 2009
Global H1N1 2009 flu vaccine market worth $ 7.03 billion by 2011
23 October 2009
EC final OK for Baxter’s H1N1 flu vaccine Celvapan
8 October 2009
Vectura $6m milestone payment for VR315 from Novartis
13 August 2009
Deal secured for pre-pandemic vaccine for UK
15 May 2009
EVM meets EC and EMEA over swine flu
30 April 2009
Baxter posts 20% jump in 1st-qtr profit
20 April 2009
Angiotech gets $25M under new Baxter Coseal deal
3 April 2009
Baxter presents data validating Gammagard
23 March 2009
Highlights of first PDCO meeting of 2009
26 January 2009
Baxter's H5N1 vacc gets nod from CHMP
15 January 2009
Halozyme gets $5.5M Baxter payment
12 January 2009
Avigen sells hemophilia candidate to Baxter
12 January 2009
Talecris buy could see CSL become leader in IVIG sales, says AMR
24 November 2008
Baxter sales up 15% in 3rd-qtr 2008
27 October 2008
Baxter initiates Ph III AD trial for Gammagard
29 September 2008
Baxter in-licenses Innocoll gentamicin surgical implant
1 September 2008
Javelin expands Dyloject deal with Baxter
11 August 2008
US drug import safety plan faces safety hurdle
11 August 2008
Baxter raises outlook on strong 2nd qtr
28 July 2008
US heparin overdoses "not preventable" by IT
21 July 2008
Austria's Pharmig looks to "sharpen" image
21 July 2008
Bioniche acquires Baxter's Enlon line
7 July 2008
BioAlliance extends Loramyc license to China
30 June 2008
Baxter's H5N1 vacc meets Ph I/II endpoints
23 June 2008
China denies heparin contamination
28 April 2008
Possible role for Gammagard in AD
28 April 2008
Baxter 2008 outlook up as 1Q results solid
28 April 2008
Heparin contamination was fraud, FDA finally admits
21 April 2008
Dev't of porphyria drug urged in Japan
7 April 2008
US heparin deaths rise to 15, contaminant identified
31 March 2008
11 defendants settle US AWP litigation
24 March 2008
Nycomed's FY 2007 EBITDA jumps 31%
24 March 2008
APP's 4th-qtr net profit falls 70% after spinout
24 March 2008
Heparin contamination case goes global
17 March 2008
FDA finds fake heparin ingredient
10 March 2008
US Congress considers action over heparin fiasco
3 March 2008
FDA says clerical mix-up led to heparin plant inspection failure
25 February 2008
No US FDA inspection for China API site
25 February 2008
Baxter's multiple-dose vial heparin linked to allergic disorders
18 February 2008
Baxter issues voluntary heparin recall
4 February 2008
Baxter's 4th-qtr income climbs 11%
4 February 2008
US hospital drug errors highlighted
3 December 2007
Baxter's 3rd-qtr 2007 net income rises 6%
29 October 2007
Baxter adds recombinant protein to portfolio
22 October 2007
Stem-cell research pioneers win Nobel Prize for Medicine
15 October 2007
Joy Thomas joins BioSante as VP, corporate development
10 September 2007
Abraxis gains expedited appro of generic cefotetan
20 August 2007
Biovitrum enters Nordic BeneFIX co-promo deal
13 August 2007
Baxter appoints Gerald Lema head of Japan unit
23 April 2007
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
